Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $65.85 --0%
EPS Growth %: +22.5%
Financial Fact:
Income from continuing operations: 937K
Today's EPS Names:
FCNCA, PBCO, ARBV, More
EPS Growth %: +22.5%
Financial Fact:
Income from continuing operations: 937K
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter came in at $500.1 million versus the consensus estimate of $470.53 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Norfolk Southern (NSC) Tops Q2 EPS by 29c
- Popular, Inc. CEO to retire in 2026, CFO named successor
- Union Pacific (UNP) Tops Q2 EPS by 22c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
